Cassie Doherty
Directeur/Membre du Conseil chez Aqdot Ltd.
Profil
Cassie Doherty is currently an Investment Director at Parkwalk Advisors Ltd.
and a Non-Executive Director at Aqdot Ltd.
She previously held positions as a Non-Executive Director at Iksuda Therapeutics Ltd.
and Relitect Ltd., a Director at Aptuscan Ltd., a Manager-Business Development at IP Group Plc, and a Program Manager at Photopharmica Ltd.
Doherty received her undergraduate and doctorate degrees from the University of Leeds.
Postes actifs de Cassie Doherty
| Sociétés | Poste | Début |
|---|---|---|
Parkwalk Advisors Ltd. (Venture Capital)
 Parkwalk Advisors Ltd. (Venture Capital) Investment ManagersFinance Parkwalk Advisors Ltd. (Parkwalk Advisors) is a venture capital firm founded in 2009 by Moray Wright and Alastair Hugh Lowell Kilgour. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01/07/2019 |
Aqdot Ltd.
 Aqdot Ltd. Chemicals: Major DiversifiedProcess Industries Aqdot Ltd. develops novel fabrication technology for smart capsules. Its technology simplifies the encapsulation process by utilizing the novel one-step, "shrink-wrap" approach based on a combination of emulsion technology and supramolecular chemistry. The company was founded by Jing Zhang, Chris Abell, Oren Scherman, and Roger Coulston in 2012 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de Cassie Doherty
| Sociétés | Poste | Fin |
|---|---|---|
Relitect Ltd.
 Relitect Ltd. Data Processing ServicesTechnology Services Relitect Ltd. develops technology for detection and analysis of proteins, small molecules and nucleic acids. It offers services to clinical diagnostics and life science industries. The company was founded by Christoph Walti and Alexander Giles Davies on November 17, 2014 and is headquartered in North Lanarkshire, The United Kingdom. | Directeur/Membre du Conseil | - |
Aptuscan Ltd.
 Aptuscan Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Avacta Group Plc, Aptuscan Ltd. provides biotechnology research in the development of various products. The company is based in Leeds, UK. Aptuscan was acquired by Avacta Group Plc on January 10, 2012 for $2.50 million. | Directeur/Membre du Conseil | - |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Directeur/Membre du Conseil | - |
| IP GROUP PLC | Corporate Officer/Principal | - |
Photopharmica Ltd.
 Photopharmica Ltd. Medical SpecialtiesHealth Technology Photopharmica Ltd. develops and discovers novel photosensitizer products. Its products pipeline includes phenothiazinium photosensitizers for use as topical therapeutic antimicrobial agents and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization. The firm's light-activated drugs kill common disease-causing microorganisms including Gram positive and negative bacteria. The company was founded in 2001 by John Lyon and is headquartered in Leeds, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Cassie Doherty
| University of Leeds | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IP GROUP PLC | Commercial Services |
| Entreprise privées | 6 |
|---|---|
Photopharmica Ltd.
Photopharmica Ltd. Medical SpecialtiesHealth Technology Photopharmica Ltd. develops and discovers novel photosensitizer products. Its products pipeline includes phenothiazinium photosensitizers for use as topical therapeutic antimicrobial agents and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization. The firm's light-activated drugs kill common disease-causing microorganisms including Gram positive and negative bacteria. The company was founded in 2001 by John Lyon and is headquartered in Leeds, the United Kingdom. | Health Technology |
Iksuda Therapeutics Ltd.
Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Health Technology |
Aptuscan Ltd.
Aptuscan Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Avacta Group Plc, Aptuscan Ltd. provides biotechnology research in the development of various products. The company is based in Leeds, UK. Aptuscan was acquired by Avacta Group Plc on January 10, 2012 for $2.50 million. | Commercial Services |
Relitect Ltd.
Relitect Ltd. Data Processing ServicesTechnology Services Relitect Ltd. develops technology for detection and analysis of proteins, small molecules and nucleic acids. It offers services to clinical diagnostics and life science industries. The company was founded by Christoph Walti and Alexander Giles Davies on November 17, 2014 and is headquartered in North Lanarkshire, The United Kingdom. | Technology Services |
Parkwalk Advisors Ltd. (Venture Capital)
Parkwalk Advisors Ltd. (Venture Capital) Investment ManagersFinance Parkwalk Advisors Ltd. (Parkwalk Advisors) is a venture capital firm founded in 2009 by Moray Wright and Alastair Hugh Lowell Kilgour. The firm is headquartered in London, United Kingdom. | Finance |
Aqdot Ltd.
Aqdot Ltd. Chemicals: Major DiversifiedProcess Industries Aqdot Ltd. develops novel fabrication technology for smart capsules. Its technology simplifies the encapsulation process by utilizing the novel one-step, "shrink-wrap" approach based on a combination of emulsion technology and supramolecular chemistry. The company was founded by Jing Zhang, Chris Abell, Oren Scherman, and Roger Coulston in 2012 and is headquartered in Cambridge, the United Kingdom. | Process Industries |
